Teladoc Stock Performance
| TDOC Stock | USD 5.91 0.38 6.04% |
The entity has a beta of 2.17, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Teladoc will likely underperform. At this point, Teladoc has a negative expected return of -0.61%. Please make sure to validate Teladoc's potential upside, as well as the relationship between the daily balance of power and price action indicator , to decide if Teladoc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Teladoc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in February 2026. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Actual Historical Performance (%)
One Day Return (6.04) | Five Day Return (5.74) | Year To Date Return (16.17) | Ten Year Return (61.92) | All Time Return (68.89) |
1 | Hims Hers Plunges 15.6 percent in 3 Months Time to Hold the Stock or Sell | 11/18/2025 |
2 | Teladoc Health Surges 7.0 percent After TytoCare AI Diagnostics Integration Is Announced Has the Growth Narrative Shifted | 11/28/2025 |
3 | Disposition of 1189 shares by Kelly Bliss of Teladoc subject to Rule 16b-3 | 12/01/2025 |
4 | Disposition of 4209 shares by Rodrigues Fernando M. of Teladoc at 7.48 subject to Rule 16b-3 | 12/03/2025 |
5 | Acquisition by Divita Charles Iii of 160 shares of Teladoc subject to Rule 16b-3 | 12/10/2025 |
6 | Disposition of 1016 shares by Evans Jason Eric of Teladoc subject to Rule 16b-3 | 12/19/2025 |
7 | Why Teladoc Stock Is Up Today | 12/22/2025 |
8 | Acquisition by Catapano Joseph Ronald of 2083 shares of Teladoc subject to Rule 16b-3 | 01/02/2026 |
9 | Disposition of 758 shares by Catapano Joseph Ronald of Teladoc at 7.145 subject to Rule 16b-3 | 01/05/2026 |
10 | Why Teladoc Dipped More Than Broader Market Today | 01/07/2026 |
11 | Is Teladoc Losing Its Edge As BetterHelp Shrinks And Rivals Crowd Into Virtual Care | 01/08/2026 |
12 | Teladoc Health Launches Enhanced 247 Care Service | 01/12/2026 |
13 | Teladoc Health 24 7 Care Upgrade Prompts Fresh Look At Apparent Valuation Discount | 01/14/2026 |
14 | Teladoc Health Reaches New 12-Month Low Heres Why | 01/16/2026 |
15 | Teladoc Health shares tumble for seven consecutive sessions | 01/20/2026 |
16 | 2 Beaten-Down Stocks That Could Sink Even More in 2026 | 01/22/2026 |
17 | Teladoc Health Hits New 1-Year Low Should You Sell | 01/27/2026 |
| Begin Period Cash Flow | 1.1 B | |
| Total Cashflows From Investing Activities | -124.1 M |
Teladoc Relative Risk vs. Return Landscape
If you would invest 874.00 in Teladoc on October 30, 2025 and sell it today you would lose (283.00) from holding Teladoc or give up 32.38% of portfolio value over 90 days. Teladoc is currently does not generate positive expected returns and assumes 2.8614% risk (volatility on return distribution) over the 90 days horizon. In different words, 25% of stocks are less volatile than Teladoc, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Teladoc Target Price Odds to finish over Current Price
The tendency of Teladoc Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 5.91 | 90 days | 5.91 | about 98.0 |
Based on a normal probability distribution, the odds of Teladoc to move above the current price in 90 days from now is about 98.0 (This Teladoc probability density function shows the probability of Teladoc Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.17 . This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Teladoc will likely underperform. Additionally Teladoc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Teladoc Price Density |
| Price |
Predictive Modules for Teladoc
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Teladoc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Teladoc Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Teladoc is not an exception. The market had few large corrections towards the Teladoc's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Teladoc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Teladoc within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.63 | |
β | Beta against Dow Jones | 2.17 | |
σ | Overall volatility | 0.69 | |
Ir | Information ratio | -0.16 |
Teladoc Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Teladoc for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Teladoc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Teladoc generated a negative expected return over the last 90 days | |
| Teladoc has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.57 B. Net Loss for the year was (1 B) with profit before overhead, payroll, taxes, and interest of 1.76 B. | |
| About 72.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Immunome Trading 8.1 percent Higher Heres Why |
Teladoc Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Teladoc Stock often depends not only on the future outlook of the current and potential Teladoc's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Teladoc's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 170.6 M | |
| Cash And Short Term Investments | 1.3 B |
Teladoc Fundamentals Growth
Teladoc Stock prices reflect investors' perceptions of the future prospects and financial health of Teladoc, and Teladoc fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Teladoc Stock performance.
| Return On Equity | -0.15 | ||||
| Return On Asset | -0.0348 | ||||
| Profit Margin | (0.09) % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 1.36 B | ||||
| Shares Outstanding | 177.47 M | ||||
| Price To Earning | (21.84) X | ||||
| Price To Book | 0.75 X | ||||
| Price To Sales | 0.41 X | ||||
| Revenue | 2.57 B | ||||
| Gross Profit | 1.76 B | ||||
| EBITDA | 31.72 M | ||||
| Net Income | (1 B) | ||||
| Cash And Equivalents | 883.7 M | ||||
| Cash Per Share | 5.47 X | ||||
| Total Debt | 1.58 B | ||||
| Debt To Equity | 0.26 % | ||||
| Current Ratio | 3.38 X | ||||
| Book Value Per Share | 7.85 X | ||||
| Cash Flow From Operations | 293.68 M | ||||
| Earnings Per Share | (1.26) X | ||||
| Market Capitalization | 1.05 B | ||||
| Total Asset | 3.52 B | ||||
| Retained Earnings | (16.23 B) | ||||
| Working Capital | 722.37 M | ||||
| Current Asset | 151.58 M | ||||
| Current Liabilities | 17.99 M | ||||
About Teladoc Performance
By analyzing Teladoc's fundamental ratios, stakeholders can gain valuable insights into Teladoc's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Teladoc has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Teladoc has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 21.31 | 33.91 | |
| Return On Tangible Assets | (0.64) | (0.67) | |
| Return On Capital Employed | (0.46) | (0.48) | |
| Return On Assets | (0.33) | (0.34) | |
| Return On Equity | (0.77) | (0.81) |
Things to note about Teladoc performance evaluation
Checking the ongoing alerts about Teladoc for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Teladoc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Teladoc generated a negative expected return over the last 90 days | |
| Teladoc has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.57 B. Net Loss for the year was (1 B) with profit before overhead, payroll, taxes, and interest of 1.76 B. | |
| About 72.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Immunome Trading 8.1 percent Higher Heres Why |
- Analyzing Teladoc's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Teladoc's stock is overvalued or undervalued compared to its peers.
- Examining Teladoc's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Teladoc's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Teladoc's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Teladoc's stock. These opinions can provide insight into Teladoc's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Teladoc Stock analysis
When running Teladoc's price analysis, check to measure Teladoc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teladoc is operating at the current time. Most of Teladoc's value examination focuses on studying past and present price action to predict the probability of Teladoc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teladoc's price. Additionally, you may evaluate how the addition of Teladoc to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |